AR016108A1 - Un derivado de bencimidazol y una composicion farmaceutica que lo contiene. - Google Patents
Un derivado de bencimidazol y una composicion farmaceutica que lo contiene.Info
- Publication number
- AR016108A1 AR016108A1 ARP980103128A ARP980103128A AR016108A1 AR 016108 A1 AR016108 A1 AR 016108A1 AR P980103128 A ARP980103128 A AR P980103128A AR P980103128 A ARP980103128 A AR P980103128A AR 016108 A1 AR016108 A1 AR 016108A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- aromatic
- alkyl
- alkenyl
- alkyloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Un derivado de benzimidazol, representado por la siguiente formula (I), o una sal del mismo: I donde R1 representa un átomo de hidrogeno, un grupo alquiloinferior, un grupo alcoxi inferior, o un grupo alquiltio inferior; R2 representa un grupo alquilo inferior aromático, que puede estar sustituido con uno o másgrupos seleccionados entre un átomo de halogeno, un grupo alquilo, un grupo haloalquilo inferior, un grupo nitro, un grupo alcoxicarbonilo inferior, un grupoaromático, un grupo alquiloxiinferior aromático, un grupo alquilo inferior cicloalquiloxi inferior, un grupo alquilo inferior aromático, un grupo alqueniloinferior aromático, un grupo alquinilo inferior aromático, un grupo alquiloxi inferior aromático, un grupo alquiloxi inferior cicloalquilo inferior, un grupoalquenilo, un grupo alcoxi inferior, un grupo alquiltio inferior, un grupo alcansulfinilo inferior, un grupo alcansulfonilo inferior, y un grupoalcansulfonilcarbamoilo inferior; R3 representa un grupo alquilo, un grupo hidroxialquilo inferior, un grupo alquenilo, un grupo aromático, un grupo aromáticohalogenado, un grupo aromático alquilo inferior, un grupo alquenilo inferior aromático, un grupo alquilo inferior aromático o un grupo alquenilo inferioraromático;y -X- es un grupo de entrecruzamiento representado por cualquiera de las siguientes formulas II a VI; composicion farmacéutica que comprende elderivado de bencimidazol que posee actividad depresora del nivel de azucar sanguíneo o actividad inhibidorade la PDES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18769697 | 1997-06-27 | ||
JP7635798 | 1998-03-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016108A1 true AR016108A1 (es) | 2001-06-20 |
Family
ID=26417500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980103128A AR016108A1 (es) | 1997-06-27 | 1998-06-26 | Un derivado de bencimidazol y una composicion farmaceutica que lo contiene. |
Country Status (15)
Country | Link |
---|---|
US (1) | US6420409B1 (es) |
EP (1) | EP1020452A4 (es) |
KR (1) | KR20010014166A (es) |
CN (1) | CN1135224C (es) |
AR (1) | AR016108A1 (es) |
AU (1) | AU748541B2 (es) |
BR (1) | BR9811273A (es) |
CA (1) | CA2294505A1 (es) |
HK (1) | HK1028246A1 (es) |
HU (1) | HUP0002324A3 (es) |
IL (1) | IL133674A0 (es) |
RU (1) | RU2243968C2 (es) |
TR (1) | TR199903277T2 (es) |
TW (1) | TW453999B (es) |
WO (1) | WO1999000373A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2295239A1 (en) * | 1997-06-27 | 1999-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Sulfonamide compounds and medicinal use thereof |
WO1999051574A1 (fr) * | 1998-04-06 | 1999-10-14 | Fujisawa Pharmaceutical Co., Ltd. | Derives d'indole |
WO2000028991A1 (fr) * | 1998-11-13 | 2000-05-25 | Fujisawa Pharmaceutical Co., Ltd. | Remedes contre le syndrome des ovaires polykystiques |
WO2000039099A1 (fr) * | 1998-12-24 | 2000-07-06 | Fujisawa Pharmaceutical Co., Ltd. | Derives de benzimidazole |
US6432989B1 (en) | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
US6525067B1 (en) | 1999-11-23 | 2003-02-25 | Pfizer Inc | Substituted heterocyclic derivatives |
EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
EP1442042A1 (en) | 2001-11-09 | 2004-08-04 | Schering Corporation | Polycyclic guanine derivative phosphodiesterase v inhibitors |
US20050032854A1 (en) * | 2001-12-03 | 2005-02-10 | Kiminori Kawahara | Insulin resistance improving agents |
US20030181461A1 (en) * | 2002-01-25 | 2003-09-25 | Lautt Wilfred Wayne | Use of phosphodiesterase antagonists to treat insulin resistance |
AU2003223093B2 (en) * | 2002-05-03 | 2010-02-04 | Israel Institute For Biological Research | Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
AU2003902860A0 (en) * | 2003-06-06 | 2003-06-26 | Daicel Chemical Industries, Ltd | Benzimidazole compounds |
US20050197376A1 (en) * | 2004-03-02 | 2005-09-08 | Fujisawa Pharmaceutical Co. Ltd. | Concomitant drugs |
EP1983992A4 (en) * | 2006-01-19 | 2010-08-18 | Abbott Lab | 2-IMINO-BENZIMIDAZOLES |
WO2011063339A1 (en) * | 2009-11-23 | 2011-05-26 | Cardioxyl Pharmaceuticals, Inc. | Nitroxyl donors for the treatment of pulmonary hypertension |
CN105919987B (zh) * | 2009-12-07 | 2020-04-03 | 约翰斯霍普金斯大学 | N-酰氧基磺酰胺和n-羟基-n-酰基磺酰胺衍生物及其用途 |
CA2782248A1 (en) | 2009-12-07 | 2011-06-16 | Cardioxyl Pharmaceuticals, Inc. | Bis-acylated hydroxylamine derivatives |
JP5990106B2 (ja) * | 2011-01-28 | 2016-09-07 | 佐藤製薬株式会社 | 縮環化合物 |
JP6456520B2 (ja) | 2015-12-11 | 2019-01-23 | 帝人ファーマ株式会社 | アミノアゾール誘導体 |
WO2017192728A1 (en) | 2016-05-03 | 2017-11-09 | Virginia Commonwealth University | Heteroatom -doped porous carbons for clean energy applications and methods for their synthesis |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE676196C (de) | 1936-08-21 | 1939-05-30 | I G Farbenindustrie Akt Ges | Verfahren zur Herstellung von Imidazolverbindungen |
US3152142A (en) | 1962-05-24 | 1964-10-06 | Dow Chemical Co | Benzimidazole compounds |
FR2291749A1 (fr) | 1974-11-20 | 1976-06-18 | Delalande Sa | Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique |
JPS51133267A (en) | 1975-05-08 | 1976-11-18 | Lilly Co Eli | Substituted 11sulphonyl benzimidazole |
US4179505A (en) | 1977-03-30 | 1979-12-18 | Janssen Pharmaceutica N.V. | 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives |
US4243806A (en) | 1979-06-13 | 1981-01-06 | Janssen Pharmaceutica N.V. | 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives |
GB2053215B (en) | 1979-06-25 | 1983-04-07 | May & Baker Ltd | Benzimidazole derivatives |
JPS625966A (ja) | 1985-07-03 | 1987-01-12 | Nippon Shinyaku Co Ltd | ベンズイミダゾ−ル誘導体 |
NZ221729A (en) | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
CA2004911A1 (en) | 1988-12-22 | 1990-06-22 | Mitsuaki Ohta | 4,5,6,7-tetrahydrobenzimidazole derivatives |
DE3928177A1 (de) * | 1989-04-08 | 1991-02-28 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
WO1991016313A1 (en) | 1990-04-13 | 1991-10-31 | Smithkline Beecham Corporation | Substituted benzimidazoles |
US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
US5703110A (en) | 1990-04-27 | 1997-12-30 | Takeda Chemical Industries, Ltd. | Benzimidazole derivatives, their production and use |
RU1836357C (ru) | 1990-07-23 | 1993-08-23 | Др.Карл Томэ ГмбХ | Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами |
DE4023369A1 (de) * | 1990-07-23 | 1992-01-30 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5602127A (en) | 1991-02-06 | 1997-02-11 | Karl Thomae Gmbh | (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists |
SI9210098B (sl) * | 1991-02-06 | 2000-06-30 | Dr. Karl Thomae | Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo |
US5594003A (en) | 1991-02-06 | 1997-01-14 | Dr. Karl Thomae Gmbh | Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists |
DE4224133A1 (de) * | 1992-07-22 | 1994-01-27 | Thomae Gmbh Dr K | Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US5591762A (en) | 1991-02-06 | 1997-01-07 | Dr. Karl Thomae Gmbh | Benzimidazoles useful as angiotensin-11 antagonists |
US5407835A (en) | 1991-07-31 | 1995-04-18 | Abbott Laboratories | Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
GB9121776D0 (en) | 1991-10-14 | 1991-11-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives and process for preparation thereof |
DE4237557A1 (de) | 1992-11-06 | 1994-05-11 | Bayer Ag | Substituierte Benzimidazole |
JPH0853424A (ja) | 1994-08-11 | 1996-02-27 | Kureha Chem Ind Co Ltd | ベンズイミダゾールスルホン酸アミド誘導体 |
GB9423910D0 (en) | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
EP0882718B1 (en) * | 1995-12-28 | 2005-08-31 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
-
1998
- 1998-06-25 TW TW087110304A patent/TW453999B/zh not_active IP Right Cessation
- 1998-06-26 AR ARP980103128A patent/AR016108A1/es unknown
- 1998-06-26 KR KR1019997012237A patent/KR20010014166A/ko not_active Application Discontinuation
- 1998-06-26 AU AU79346/98A patent/AU748541B2/en not_active Ceased
- 1998-06-26 WO PCT/JP1998/002885 patent/WO1999000373A1/ja not_active Application Discontinuation
- 1998-06-26 CA CA002294505A patent/CA2294505A1/en not_active Abandoned
- 1998-06-26 HU HU0002324A patent/HUP0002324A3/hu unknown
- 1998-06-26 IL IL13367498A patent/IL133674A0/xx unknown
- 1998-06-26 RU RU2000101811/04A patent/RU2243968C2/ru not_active IP Right Cessation
- 1998-06-26 CN CNB988085798A patent/CN1135224C/zh not_active Expired - Fee Related
- 1998-06-26 US US09/446,749 patent/US6420409B1/en not_active Expired - Fee Related
- 1998-06-26 BR BR9811273-2A patent/BR9811273A/pt not_active IP Right Cessation
- 1998-06-26 EP EP98929723A patent/EP1020452A4/en not_active Withdrawn
- 1998-06-26 TR TR1999/03277T patent/TR199903277T2/xx unknown
-
2000
- 2000-11-22 HK HK00107463A patent/HK1028246A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1135224C (zh) | 2004-01-21 |
HUP0002324A3 (en) | 2001-07-30 |
AU7934698A (en) | 1999-01-19 |
RU2243968C2 (ru) | 2005-01-10 |
CA2294505A1 (en) | 1999-01-07 |
HK1028246A1 (en) | 2001-02-09 |
HUP0002324A2 (hu) | 2001-05-28 |
EP1020452A4 (en) | 2003-04-02 |
WO1999000373A1 (fr) | 1999-01-07 |
TW453999B (en) | 2001-09-11 |
US6420409B1 (en) | 2002-07-16 |
WO1999000373A8 (fr) | 2000-07-20 |
AU748541B2 (en) | 2002-06-06 |
BR9811273A (pt) | 2000-07-18 |
CN1268123A (zh) | 2000-09-27 |
KR20010014166A (ko) | 2001-02-26 |
IL133674A0 (en) | 2001-04-30 |
TR199903277T2 (xx) | 2000-07-21 |
EP1020452A1 (en) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR016108A1 (es) | Un derivado de bencimidazol y una composicion farmaceutica que lo contiene. | |
PE20050346A1 (es) | Glucopiranosiloxi-pirazoles como inhibidores del co-transportador de glucosa dependiente de sodio (sglt2) | |
NO20005237L (no) | Heterocyklisk substituerte amider anvendt som calpain- inhibitorer | |
PE20040411A1 (es) | Compuestos de aril cetona pirrolo triazina | |
DOP2006000063A (es) | Derivados de ciclopropanocarboxamida | |
ES2053609T3 (es) | Derivados de urea inhibidores de lipoxigenasa. | |
AR042273A1 (es) | Derivados de pirazol, procedimiento para prepararlos y las composiciones farmaceuticas que los contienen | |
AR038717A1 (es) | Ciclopropil-azol-carboxamidas | |
ES2032899T3 (es) | Agente cosmetico para aplicacion externa y su uso. | |
ITMI920973A1 (it) | Derivati di adenosina ad attivita' a2 agonista | |
BR9712085A (pt) | Inibidores de metaloprotease heterocìclicos | |
DK1598338T5 (da) | 1-(4-piperidinyl)-1,3-dihydro-2H-indol-2-on-derivater og relaterede forbindelser som nociceptinanaloger og ORL1-ligander til behandlingen af smerte | |
AR050598A2 (es) | Composicion funguicida sinergica, procedimiento para combatir hongos nocivos y uso de los compuestos que integran dicha composicion para la preparacion de dichas mezclas sinergicas | |
DE60233884D1 (de) | 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-derivate als pde-4-hemmer zur behandlung von neurologischen syndromen | |
AR020165A1 (es) | Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos | |
ES2255190T3 (es) | Compuestos indol 2,3-sustituidos como inhibidores de cox-2. | |
EA200200207A1 (ru) | Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы | |
ES2074191T3 (es) | Oxazolidinonas. | |
DK0610336T3 (da) | Behandling af neurologiske tilstande ved hjælp af en interleukin-1-hæmmende forbindelse | |
MX9203939A (es) | Derivados de hidroisoquinolina y composiciones farmaceuticas que los contienen. | |
AR021992A1 (es) | Mezcla fungicida. | |
DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
MX9202994A (es) | Derivados de 2-aminoacetamida. | |
DK54484D0 (da) | Substituerede alkanthiocarboxylsyre-derivater,fremgangsmaade til deres fremstilling samt deres anvendelse som herbicider | |
DK203784A (da) | 1-(4-(4-(fluoralkylmethylthio- eller -sulfinyl- eller -sulfonyl-)-phenoxy)phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)trioner, fremgangsmaade til fremstilling deraf og deres anvendelse som coccidiosemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |